Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Title
Intervention Indication Therapeutic Area Year Actions
Ravulizumab for paroxysmal nocturnal haemoglobinuria in paediatrics Ravulizumab (ALXN1210; Ultomiris) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2021 View  |  Download
Ranibizumab Biosimilar for Age-related Macular Degeneration Ranibizumab biosimilar (FYB201; BI695511; PF582; QL1205; Xlucane; SB11) Age-related macular degeneration (AMD) Ophthalmology 2021 View  |  Download
Quizartinib with chemotherapy for FLT3-ITD positive acute myeloid leukaemia Quizartinib (AC220) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2021 View  |  Download
Pralsetinib for treating thyroid cancer Pralsetinib (BLU-667; Gavreto) Thyroid cancer Oncology 2021 View  |  Download
PLX-PAD for injured gluteal musculature following arthroplasty PLX-PAD Injured gluteal musculature Musculoskeletal System 2021 View  |  Download
Pirtobrutinib for mantle cell lymphoma Pirtobrutinib (LY3527727; LOXO-305) Mantle cell lymphoma Haematological Cancer and Lymphomas 2021 View  |  Download
Phelinun for reduced intensity conditioning treatment prior to allogeneic haematopoietic stem cell transplantation Melphalan hydrochloride (Cydex; CDX-353; Phelinun) Acute myeloid leukaemia (AML) , Hodgkin lymphoma , Multiple myeloma (MM) , Neuroblastoma , Non-Hodgkin lymphoma (NHL) , Ovarian cancer Female Reproductive Cancer , Haematological Cancer and Lymphomas , Neurological Cancer 2021 View  |  Download
Pembrolizumab plus chemotherapy for the treatment of gastric cancer or gastro-oesophageal junction cancer – First Line Pembrolizumab (Keytruda; MK-3475) Gastric cancer , Gastro-oesophageal junction cancer Gastrointestinal Cancer 2021 View  |  Download
Pembrolizumab in combination with pemetrexed and cisplatin for previously untreated advanced malignant pleural mesothelioma Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Malignant pleural mesothelioma (MPM) Lung and Respiratory Cancer 2021 View  |  Download
Pembrolizumab in combination with olaparib for treatment of metastatic squamous non-small cell lung cancer Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications